Details for New Drug Application (NDA): 062603
✉ Email this page to a colleague
NDA 062603 describes NYSTATIN-TRIAMCINOLONE ACETONIDE, which is a drug marketed by Pharmaderm and is included in one NDA. Additional details are available on the NYSTATIN-TRIAMCINOLONE ACETONIDE profile page.
The generic ingredient in NYSTATIN-TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
The generic ingredient in NYSTATIN-TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
Summary for 062603
| Tradename: | NYSTATIN-TRIAMCINOLONE ACETONIDE |
| Applicant: | Pharmaderm |
| Ingredient: | nystatin; triamcinolone acetonide |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 100,000 UNITS/GM;0.1% | ||||
| Approval Date: | Oct 9, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
